PHENPROCOUMON - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for phenprocoumon and what is the scope of patent protection?
Phenprocoumon
is the generic ingredient in one branded drug marketed by Organon Usa Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for PHENPROCOUMON
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Clinical Trials: | 24 |
Patent Applications: | 5,270 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHENPROCOUMON at DailyMed |
Recent Clinical Trials for PHENPROCOUMON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stiftung Institut fuer Herzinfarktforschung | Phase 4 |
Charite University, Berlin, Germany | Phase 4 |
Paolo Ghia | Phase 2 |
Medical Subject Heading (MeSH) Categories for PHENPROCOUMON
US Patents and Regulatory Information for PHENPROCOUMON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | LIQUAMAR | phenprocoumon | TABLET;ORAL | 011228-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |